Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07372729 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Smartwatch-based Intervention for Cardiovascular Health (SWITCH)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 14, 2026 (before its estimated September 24, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Sep 15, 2026 to Sep 24, 2026
    • Start date changed from estimate of Mar 15, 2026 to Mar 24, 2026
    v3
  2. Recruitment opened
    • Trial sites expanded: 0 → 3 locations
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Beijing Anzhen Hospital
102 trials monitored
See 3 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
This study aims to employ a cluster randomized controlled trial to evaluate the effectiveness of an mHealth-Based Multi-faceted Cardiovascular Health Intervention Model among Overweight/Obese Individuals with Cardiometabolic Preconditions, thereby providing theoretical foundations and practical guidance for the prevention and management of this population.
Trial Details
NCT Number NCT07372729
Lead Sponsor Beijing Anzhen Hospital
Collaborators: Beijing Chao Yang Hospital, Cangzhou Central Hospital, Health Community Group of Yuhuan People's Hosptial
Conditions
(from sponsor)		 Prehypertension, Borderline Dyslipidemia, Overweight , Obesity, Prediabetes
Related terms Obesity, Overweight, Prediabetic State, Prehypertension
Enrollment 1,400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov